
Life Science Review
Digital Therapeutics, The Future of Medical Treatments


Carolynn Walters
With digitisation taking over the healthcare space, digital therapeutics (DTx) have likely emerged as an effective alternative in treating diseases and disorders.
Implementing digital therapy-driven therapies has gained increased significance in recent times, owing to its induced capabilities like direct patient access, lower treatment costs, and high adherence towards a healthy lifestyle. That is, employing digital therapy in therapeutics aids in curing varied illnesses, favouring advancements in global medicine. Digital therapy (DTx) harnesses evidence-based software and undergoes critical clinical evaluation to offer medical intervention to patients—treatment, management, and prevention of varied diseases and disorders.
Digital treatments are often evidence-based programming techniques that pass critical clinical examinations, and thus, healthcare is all set to be substantially rebuilt and improved on account of its quick adoption of new technologies. As a result, pharmaceutical businesses, especially large-scale ones, are accelerating their investments in the digital therapeutics space for an improvised patient outcome, thereby forming strategic partnerships with technology companies.
The very innovative therapeutic pattern offers enhanced and acute access to patients over their health conditions, making them active participants in their treatments, unlike traditional drug therapy—reducing barriers in the healthcare system. Implementing digital therapy programs in therapeutic settings often automates the regular duties of patients suffering from chronic illnesses, who intend to skip treatment or cease to exercise as they grow weary.
For instance, enabling medication notifications from Google Calendar and patient journals via the ability to track varied health indicators facilitates induced solutions like the traditional analogue methods. Meanwhile, certain categories of applications are yet to attain the approval procedure with discrete functioning– analysing patients’ data and offering critical life cycle routines. Measures like diabetes prevention programs, telemedicine, electronic document management, the Internet of Medical Things (IoMT), and medical image analysis are digital-driven therapeutic measures gaining momentum in recent times, owing to their formidable opportunities.
Technology intervention in the healthcare sector is seamless; however, it is yet to improve in certain areas where traditional medicines excel as frontiers. However, implementing digital therapeutics in the medical space often complements the pre-existing therapeutic methods, providing induced treatment outcomes with reduced or no negative impacts. With digital therapy (DT) evolving at an increased pace, new health assessment tactics are critical in analysing the transitions in the sector. Wherein increased funding is crucial for the creation and distribution of digital healthcare solutions like DT tools and surveillance technologies.
Digital therapy solutions define the stages and approach towards healthcare delivery, in addition to assisting doctors with critical patient care. Further, an increased global population has likely shifted toward DT, underscoring its significance in the medical space.
